Long-term Arrhythmia Monitoring in Cryptogenic Stroke: Who, How, and for How Long?

The Open Cardiovascular Medicine Journal Pub Date : 2016-05-27 eCollection Date: 2016-01-01 DOI:10.2174/1874192401610010089
Mayra Montalvo, Rushna Ali, Brian Silver, Muhib Khan
{"title":"Long-term Arrhythmia Monitoring in Cryptogenic Stroke: Who, How, and for How Long?","authors":"Mayra Montalvo,&nbsp;Rushna Ali,&nbsp;Brian Silver,&nbsp;Muhib Khan","doi":"10.2174/1874192401610010089","DOIUrl":null,"url":null,"abstract":"<p><p>Cryptogenic stroke and transient ischemic attack (TIA) account for approximately one-third of stroke patients [1]. Paroxys-mal atrial fibrillation (PAF) has been suggested as a major etiology of these cryptogenic strokes [2, 3]. PAF can be difficult to diagnose because it is intermittent, often brief, and asymptomatic. PAF might be more prevalent than persistent atrial fibrillation in stroke and TIA patients, especially in younger populations [4, 5]. In patients with atrial fibrillation, anticoagulation provides significant risk reduction [6]. A new generation of oral anticoagulants has been approved for non-valvular atrial fibrillation, providing a variety of therapeutic options for patients with atrial fibrillation and risk of stroke [7]. Prior practice included an admission electrocardiogram (ECG) and continuous telemetry monitoring while in hospital [8]. However, this approach can lead to under-detection of brief asymptomatic events, which can occur at variable intervals, often outside of the hospital setting. Technological advancements have led to devices that can monitor cardiac rhythms outside of the hospital for longer durations resulting in higher yield of detection of atrial fibrillation events. Moreover, recent studies show that the normal monitoring time for arrhythmias may be shorter than ideal in order to detect atrial fibrillation, and increasing this interval could significantly improve detection of atrial fibrillation in these patients [9, 10]. The aim of this study is to review the literature in order to define what subgroup of patients, with what methodologies, and for how long monitoring for atrial fibrillation should occur in patients presenting with cryptogenic stroke. </p>","PeriodicalId":504447,"journal":{"name":"The Open Cardiovascular Medicine Journal","volume":"10 ","pages":"89-93"},"PeriodicalIF":0.0000,"publicationDate":"2016-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/18/ea/TOCMJ-10-89.PMC4897003.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Open Cardiovascular Medicine Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874192401610010089","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Cryptogenic stroke and transient ischemic attack (TIA) account for approximately one-third of stroke patients [1]. Paroxys-mal atrial fibrillation (PAF) has been suggested as a major etiology of these cryptogenic strokes [2, 3]. PAF can be difficult to diagnose because it is intermittent, often brief, and asymptomatic. PAF might be more prevalent than persistent atrial fibrillation in stroke and TIA patients, especially in younger populations [4, 5]. In patients with atrial fibrillation, anticoagulation provides significant risk reduction [6]. A new generation of oral anticoagulants has been approved for non-valvular atrial fibrillation, providing a variety of therapeutic options for patients with atrial fibrillation and risk of stroke [7]. Prior practice included an admission electrocardiogram (ECG) and continuous telemetry monitoring while in hospital [8]. However, this approach can lead to under-detection of brief asymptomatic events, which can occur at variable intervals, often outside of the hospital setting. Technological advancements have led to devices that can monitor cardiac rhythms outside of the hospital for longer durations resulting in higher yield of detection of atrial fibrillation events. Moreover, recent studies show that the normal monitoring time for arrhythmias may be shorter than ideal in order to detect atrial fibrillation, and increasing this interval could significantly improve detection of atrial fibrillation in these patients [9, 10]. The aim of this study is to review the literature in order to define what subgroup of patients, with what methodologies, and for how long monitoring for atrial fibrillation should occur in patients presenting with cryptogenic stroke.

隐源性卒中的长期心律失常监测:谁、如何监测、监测多长时间?
隐源性卒中和短暂性脑缺血发作(TIA)约占卒中患者的三分之一[1]。阵发性心房颤动(PAF)已被认为是这些隐源性中风的主要病因[2,3]。PAF可能很难诊断,因为它是间歇性的,通常是短暂的,无症状的。在卒中和TIA患者中,尤其是在年轻人群中,PAF可能比持续性房颤更普遍[4,5]。对于房颤患者,抗凝治疗可显著降低风险[6]。新一代口服抗凝剂已被批准用于治疗非瓣膜性心房颤动,为有卒中风险的心房颤动患者提供多种治疗选择[7]。之前的实践包括入院心电图(ECG)和住院期间的连续遥测监测[8]。然而,这种方法可能导致短暂无症状事件的检测不足,这些事件可能以不同的间隔发生,通常发生在医院之外。技术的进步使得设备可以在医院外监测心律更长时间,从而提高心房颤动事件的检出率。此外,最近的研究表明,心律失常的正常监测时间可能比发现房颤的理想时间短,增加这一时间间隔可以显著提高这类患者对房颤的发现[9,10]。本研究的目的是回顾文献,以确定哪些亚组的患者,用什么方法,多长时间监测心房颤动应该发生在隐情性卒中患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信